No Data
No Data
Market Whales and Their Recent Bets on MRK Options
High-rolling investors have positioned themselves bullish on Merck & Co (NYSE:MRK), and it's important for retail traders to take note.\This activity came to our attention today through Benzinga's tra
Merck Insiders Sold US$15m Of Shares Suggesting Hesitancy
As More Rare Disease Therapies Launch, Their Prices Are Rising
10 Best Low Volatility ETFs To Buy
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
With 78% Ownership of the Shares, Merck & Co., Inc. (NYSE:MRK) Is Heavily Dominated by Institutional Owners
Key Insights Institutions' substantial holdings in Merck implies that they have significant influence over the company's share price 45% of the business is held by the top 25 shareholders Insider
No Data